OKTAL PHARMA d.o.o. secures contract for Various medicinal products - Procurement of medicines pembrolizumab, ublituximab, avapritinib and zanubrutinib until the conclusion of the Agreement after the implementation of the joint procurement procedure

Croatia, Sept. 17 -- Croatia based OKTAL PHARMA d.o.o. has secured contract from Opca bolnica Dr. Josip Bencevic Slavonski Brod for Various medicinal products - Procurement of medicines pembrolizumab, ublituximab, avapritinib and zanubrutinib until the conclusion of the Agreement after the implementation of the joint procurement procedure . The value of the contract is worth 28840 EUR .

Published by HT Digital Content Services with permission from Pivotal Sources....